Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

What did we learn from CTLA-4 insufficiency on the human immune system?

Mitsuiki N, Schwab C, Grimbacher B.

Immunol Rev. 2019 Jan;287(1):33-49. doi: 10.1111/imr.12721. Review.

PMID:
30565239
2.

B-lymphoblastic lymphoma with TCF3-PBX1 fusion gene.

Kubota-Tanaka M, Osumi T, Miura S, Tsujimoto H, Imamura T, Nishimura A, Oki K, Nakamura K, Miyamoto S, Inoue K, Inoue M, Kamiya T, Yanagimachi M, Okano T, Mitsuiki N, Isoda T, Imai K, Kanegane H, Morio T, Kounami S, Endo M, Kato M, Takagi M.

Haematologica. 2019 Jan;104(1):e35-e37. doi: 10.3324/haematol.2018.199885. Epub 2018 Sep 27. No abstract available.

3.

CTLA-4 regulates human Natural Killer cell effector functions.

Lougaris V, Tabellini G, Baronio M, Patrizi O, Gazzurelli L, Mitsuiki N, Pozzi MR, Grimbacher B, Parolini S, Plebani A.

Clin Immunol. 2018 Sep;194:43-45. doi: 10.1016/j.clim.2018.06.010. Epub 2018 Jun 30. No abstract available.

PMID:
29966715
4.

Hematopoietic cell transplantation for myeloid/NK cell precursor acute leukemia in second remission.

Noguchi Y, Tomizawa D, Hiroki H, Miyamoto S, Tezuka M, Miyawaki R, Tanaka-Kubota M, Okano T, Kobayashi C, Mitsuiki N, Aoki Y, Imai K, Kajiwara M, Kanegane H, Morio T, Takagi M.

Clin Case Rep. 2018 Apr 10;6(6):1023-1028. doi: 10.1002/ccr3.1506. eCollection 2018 Jun.

5.

Hematopoietic stem cell transplantation for progressive combined immunodeficiency and lymphoproliferation in patients with activated phosphatidylinositol-3-OH kinase δ syndrome type 1.

Okano T, Imai K, Tsujita Y, Mitsuiki N, Yoshida K, Kamae C, Honma K, Mitsui-Sekinaka K, Sekinaka Y, Kato T, Hanabusa K, Endo E, Takashima T, Hiroki H, Yeh TW, Tanaka K, Nagahori M, Tsuge I, Bando Y, Iwasaki F, Shikama Y, Inoue M, Kimoto T, Moriguchi N, Yuza Y, Kaneko T, Suzuki K, Matsubara T, Maruo Y, Kunitsu T, Waragai T, Sano H, Hashimoto Y, Tasaki K, Suzuki O, Shirakawa T, Kato M, Uchiyama T, Ishimura M, Tauchi T, Yagasaki H, Jou ST, Yu HH, Kanegane H, Kracker S, Durandy A, Kojima D, Muramatsu H, Wada T, Inoue Y, Takada H, Kojima S, Ogawa S, Ohara O, Nonoyama S, Morio T.

J Allergy Clin Immunol. 2019 Jan;143(1):266-275. doi: 10.1016/j.jaci.2018.04.032. Epub 2018 May 18.

PMID:
29778502
6.

Dysregulation of Epstein-Barr Virus Infection in Hypomorphic ZAP70 Mutation.

Hoshino A, Takashima T, Yoshida K, Morimoto A, Kawahara Y, Yeh TW, Okano T, Yamashita M, Mitsuiki N, Imai K, Sakatani T, Nakazawa A, Okuno Y, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Ogawa S, Kojima S, Morio T, Kanegane H.

J Infect Dis. 2018 Jul 24;218(5):825-834. doi: 10.1093/infdis/jiy231.

PMID:
29684201
7.

Hematopoietic stem cell transplantation for pulmonary alveolar proteinosis associated with primary immunodeficiency disease.

Tanaka-Kubota M, Shinozaki K, Miyamoto S, Yanagimachi M, Okano T, Mitsuiki N, Ueki M, Yamada M, Imai K, Takagi M, Agematsu K, Kanegane H, Morio T.

Int J Hematol. 2018 May;107(5):610-614. doi: 10.1007/s12185-017-2375-1. Epub 2017 Nov 28.

PMID:
29185156
8.

Effect of reduced-intensity conditioning and the risk of late-onset non-infectious pulmonary complications in pediatric patients.

Nagasawa M, Mitsuiki N, Aoki Y, Ono T, Isoda T, Imai K, Takagi M, Kajiwara M, Kanegane H, Morio T.

Eur J Haematol. 2017 Dec;99(6):525-531. doi: 10.1111/ejh.12967. Epub 2017 Oct 4.

PMID:
28888028
9.

Maternal T and B cell engraftment in two cases of X-linked severe combined immunodeficiency with IgG1 gammopathy.

Okano T, Nishikawa T, Watanabe E, Watanabe T, Takashima T, Yeh TW, Yamashita M, Tanaka-Kubota M, Miyamoto S, Mitsuiki N, Takagi M, Kawano Y, Mochizuki Y, Imai K, Kanegane H, Morio T.

Clin Immunol. 2017 Oct;183:112-120. doi: 10.1016/j.clim.2017.08.003. Epub 2017 Aug 3.

PMID:
28780374
10.

Multicolor Flow Cytometry for the Diagnosis of Primary Immunodeficiency Diseases.

Takashima T, Okamura M, Yeh TW, Okano T, Yamashita M, Tanaka K, Hoshino A, Mitsuiki N, Takagi M, Ishii E, Imai K, Kanegane H, Morio T.

J Clin Immunol. 2017 Jul;37(5):486-495. doi: 10.1007/s10875-017-0405-7. Epub 2017 Jun 8.

PMID:
28597144
11.

Common Variable Immunodeficiency Caused by FANC Mutations.

Sekinaka Y, Mitsuiki N, Imai K, Yabe M, Yabe H, Mitsui-Sekinaka K, Honma K, Takagi M, Arai A, Yoshida K, Okuno Y, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Muramatsu H, Kojima S, Hira A, Takata M, Ohara O, Ogawa S, Morio T, Nonoyama S.

J Clin Immunol. 2017 Jul;37(5):434-444. doi: 10.1007/s10875-017-0396-4. Epub 2017 May 11.

PMID:
28493158
12.

HLA haploidentical hematopoietic cell transplantation using clofarabine and busulfan for refractory pediatric hematological malignancy.

Takagi M, Ishiwata Y, Aoki Y, Miyamoto S, Hoshino A, Matsumoto K, Nishimura A, Tanaka M, Yanagimachi M, Mitsuiki N, Imai K, Kanegane H, Kajiwara M, Takikawa K, Mae T, Tomita O, Fujimura J, Yasuhara M, Tomizawa D, Mizutani S, Morio T.

Int J Hematol. 2017 May;105(5):686-691. doi: 10.1007/s12185-017-2187-3. Epub 2017 Feb 9.

PMID:
28185203
13.

Novel compound heterozygous mutations in a Japanese girl with Janus kinase 3 deficiency.

Sato T, Okano T, Tanaka-Kubota M, Kimura S, Miyamoto S, Ono S, Yamashita M, Mitsuiki N, Takagi M, Imai K, Kajiwara M, Ebato T, Ogata S, Oda H, Ohara O, Kanegane H, Morio T.

Pediatr Int. 2016 Oct;58(10):1076-1080. doi: 10.1111/ped.13070. Epub 2016 Sep 4.

PMID:
27593409
14.

Severe neonatal CMV infection complicated with thrombotic microangiopathy successfully treated with ganciclovir.

Mitsuiki N, Tamanuki K, Sei K, Ito J, Kishi A, Kobayashi K, Hatai Y, Nagasawa M.

J Infect Chemother. 2017 Feb;23(2):107-110. doi: 10.1016/j.jiac.2016.08.007. Epub 2016 Sep 11.

PMID:
27627852
15.

X-linked agammaglobulinemia: Twenty years of single-center experience from North West India.

Singh S, Rawat A, Suri D, Gupta A, Garg R, Saikia B, Minz RW, Sehgal S, Chan KW, Lau YL, Kamae C, Honma K, Nakagawa N, Imai K, Nonoyama S, Oshima K, Mitsuiki N, Ohara O.

Ann Allergy Asthma Immunol. 2016 Oct;117(4):405-411. doi: 10.1016/j.anai.2016.07.044. Epub 2016 Sep 1.

PMID:
27593100
16.

Phosphatase and tensin homolog (PTEN) mutation can cause activated phosphatidylinositol 3-kinase δ syndrome-like immunodeficiency.

Tsujita Y, Mitsui-Sekinaka K, Imai K, Yeh TW, Mitsuiki N, Asano T, Ohnishi H, Kato Z, Sekinaka Y, Zaha K, Kato T, Okano T, Takashima T, Kobayashi K, Kimura M, Kunitsu T, Maruo Y, Kanegane H, Takagi M, Yoshida K, Okuno Y, Muramatsu H, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Kojima S, Ogawa S, Ohara O, Okada S, Kobayashi M, Morio T, Nonoyama S.

J Allergy Clin Immunol. 2016 Dec;138(6):1672-1680.e10. doi: 10.1016/j.jaci.2016.03.055. Epub 2016 Jul 14.

PMID:
27426521
17.

Genomic analysis of clonal origin of Langerhans cell histiocytosis following acute lymphoblastic leukaemia.

Kato M, Seki M, Yoshida K, Sato Y, Oyama R, Arakawa Y, Kishimoto H, Taki T, Akiyama M, Shiraishi Y, Chiba K, Tanaka H, Mitsuiki N, Kajiwara M, Mizutani S, Sanada M, Miyano S, Ogawa S, Koh K, Takita J.

Br J Haematol. 2016 Oct;175(1):169-72. doi: 10.1111/bjh.13841. Epub 2015 Nov 5. No abstract available.

PMID:
26537828
18.

Mutations in Bruton's tyrosine kinase impair IgA responses.

Mitsuiki N, Yang X, Bartol SJ, Grosserichter-Wagener C, Kosaka Y, Takada H, Imai K, Kanegane H, Mizutani S, van der Burg M, van Zelm MC, Ohara O, Morio T.

Int J Hematol. 2015 Mar;101(3):305-13. doi: 10.1007/s12185-015-1732-1. Epub 2015 Jan 15.

PMID:
25589397
19.

Cord blood transplantation is associated with rapid B-cell neogenesis compared with BM transplantation.

Nakatani K, Imai K, Shigeno M, Sato H, Tezuka M, Okawa T, Mitsuiki N, Isoda T, Tomizawa D, Takagi M, Nagasawa M, Kajiwara M, Yamamoto M, Arai A, Miura O, Kamae C, Nakagawa N, Honma K, Nonoyama S, Mizutani S, Morio T.

Bone Marrow Transplant. 2014 Sep;49(9):1155-61. doi: 10.1038/bmt.2014.123. Epub 2014 Jun 30.

PMID:
24978139
20.

A nationwide survey of Aicardi-Goutières syndrome patients identifies a strong association between dominant TREX1 mutations and chilblain lesions: Japanese cohort study.

Abe J, Nakamura K, Nishikomori R, Kato M, Mitsuiki N, Izawa K, Awaya T, Kawai T, Yasumi T, Toyoshima I, Hasegawa K, Ohshima Y, Hiragi T, Sasahara Y, Suzuki Y, Kikuchi M, Osaka H, Ohya T, Ninomiya S, Fujikawa S, Akasaka M, Iwata N, Kawakita A, Funatsuka M, Shintaku H, Ohara O, Ichinose H, Heike T.

Rheumatology (Oxford). 2014 Mar;53(3):448-58. doi: 10.1093/rheumatology/ket372. Epub 2013 Dec 3.

PMID:
24300241
21.

Chronic granulomatous disease: two decades of experience from a tertiary care centre in North West India.

Rawat A, Singh S, Suri D, Gupta A, Saikia B, Minz RW, Sehgal S, Vaiphei K, Kamae C, Honma K, Nakagawa N, Imai K, Nonoyama S, Oshima K, Mitsuiki N, Ohara O, Chan KW, Lau YL.

J Clin Immunol. 2014 Jan;34(1):58-67. doi: 10.1007/s10875-013-9963-5. Epub 2013 Nov 26.

PMID:
24276928
22.

Early coagulation disorder after allogeneic stem cell transplantation is a strong prognostic factor for transplantation-related mortality, and intervention with recombinant human thrombomodulin improves the outcome: a single-center experience.

Nagasawa M, Ohkawa T, Endo A, Mitsuiki N, Ono T, Aoki Y, Isoda T, Tomizawa D, Takagi M, Kajiwara M, Morio T, Mizutani S.

Int J Hematol. 2013 Nov;98(5):533-42. doi: 10.1007/s12185-013-1443-4. Epub 2013 Oct 1.

PMID:
24081926
23.

Novel mutation of IL2RG gene in a Korean boy with X-linked severe combined immunodeficiency.

Lee YW, Yang EA, Kang HJ, Yang X, Mitsuiki N, Ohara O, Miyawaki T, Kanegane H, Lee JH.

J Investig Allergol Clin Immunol. 2013;23(1):65-7. No abstract available.

24.

Common variable immunodeficiency classification by quantifying T-cell receptor and immunoglobulin κ-deleting recombination excision circles.

Kamae C, Nakagawa N, Sato H, Honma K, Mitsuiki N, Ohara O, Kanegane H, Pasic S, Pan-Hammarström Q, van Zelm MC, Morio T, Imai K, Nonoyama S.

J Allergy Clin Immunol. 2013 May;131(5):1437-40.e5. doi: 10.1016/j.jaci.2012.10.059. Epub 2012 Dec 28. No abstract available.

PMID:
23273952
25.

Irreversible leukoencephalopathy after reduced-intensity stem cell transplantation in a dyskeratosis congenita patient with TINF2 mutation.

Isoda T, Mitsuiki N, Ohkawa T, Kaneko S, Endo A, Ono T, Aoki Y, Tomizawa D, Kajiwara M, Araki S, Nagasawa M, Morio T, Takagi M, Mizutani S.

J Pediatr Hematol Oncol. 2013 May;35(4):e178-82. doi: 10.1097/MPH.0b013e318279e5ca.

PMID:
23242325
26.

A novel Wiskott-Aldrich syndrome protein mutation in an infant with thrombotic thrombocytopenic purpura.

Kawasaki Y, Toyoda H, Otsuki S, Iwasa T, Iwamoto S, Azuma E, Itoh-Habe N, Wada H, Fujimura Y, Morio T, Imai K, Mitsuiki N, Ohara O, Komada Y.

Eur J Haematol. 2013 Feb;90(2):164-8. doi: 10.1111/ejh.12057. Epub 2013 Jan 7.

PMID:
23237501
27.

Clinical profile and genetic basis of Wiskott-Aldrich syndrome at Chandigarh, North India.

Suri D, Singh S, Rawat A, Gupta A, Kamae C, Honma K, Nakagawa N, Imai K, Nonoyama S, Oshima K, Mitsuiki N, Ohara O, Bilhou-Nabera C, Proust A, Ahluwalia J, Dogra S, Saikia B, Minz RW, Sehgal S.

Asian Pac J Allergy Immunol. 2012 Mar;30(1):71-8.

28.

Wiskott-Aldrich syndrome mutation in two Turkish siblings with X-linked thrombocytopenia.

Leblebisatan G, Bay A, Mitsuiki N, Ohara O, Honma K, İmai K, Nonoyama S.

Turk J Haematol. 2011 Jun 5;28(2):139-41. doi: 10.5152/tjh.2011.31.

29.

Quantification of κ-deleting recombination excision circles in Guthrie cards for the identification of early B-cell maturation defects.

Nakagawa N, Imai K, Kanegane H, Sato H, Yamada M, Kondoh K, Okada S, Kobayashi M, Agematsu K, Takada H, Mitsuiki N, Oshima K, Ohara O, Suri D, Rawat A, Singh S, Pan-Hammarström Q, Hammarström L, Reichenbach J, Seger R, Ariga T, Hara T, Miyawaki T, Nonoyama S.

J Allergy Clin Immunol. 2011 Jul;128(1):223-225.e2. doi: 10.1016/j.jaci.2011.01.052. Epub 2011 Mar 11. No abstract available.

PMID:
21397315
30.

Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation.

Takagi M, Shinoda K, Piao J, Mitsuiki N, Takagi M, Matsuda K, Muramatsu H, Doisaki S, Nagasawa M, Morio T, Kasahara Y, Koike K, Kojima S, Takao A, Mizutani S.

Blood. 2011 Mar 10;117(10):2887-90. doi: 10.1182/blood-2010-08-301515. Epub 2010 Nov 9.

31.

Pharmacokinetic monitoring is still required for intravenous busulfan in SCT for small children.

Nagasawa M, Mitsuiki N, Ono T, Takagi M, Oda H, Yasuhara M, Mizutani S.

Int J Hematol. 2010 May;91(4):728-30. doi: 10.1007/s12185-010-0572-2. Epub 2010 Apr 27. No abstract available.

PMID:
20422470
32.

Immunologically silent cancer clone transmission from mother to offspring.

Isoda T, Ford AM, Tomizawa D, van Delft FW, De Castro DG, Mitsuiki N, Score J, Taki T, Morio T, Takagi M, Saji H, Greaves M, Mizutani S.

Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17882-5. doi: 10.1073/pnas.0904658106. Epub 2009 Oct 12.

Supplemental Content

Loading ...
Support Center